Search Results

Your search for Syed A. Abutalib, MD and Alex Francisco Herrera, MD,Syed A. Abutalib, MD and Alex Francisco Herrera, MD matches 2 pages

Showing 1 - 2

By Syed Ali Abutalib, MD, and Alex Francisco Herrera, MD / February 25, 2025

Early-Stage Classic Hodgkin Lymphoma

“It isn’t the mountains ahead to climb that wear you out; it’s the pebble in your shoe.” —Muhammad Ali Long-term survival in early-stage classic Hodgkin lymphoma (cHL) was first made possible by the introduction of the mantle and inverted Y fields of radiotherapy in the 1960s. The addition of...

lymphoma

By Syed A. Abutalib, MD and Alex Francisco Herrera, MD / April 25, 2024

Advanced-Stage Classical Hodgkin Lymphoma

Classical Hodgkin lymphoma (HL) is a highly curable disease, but up to 25% of patients will develop relapsed or refractory classical HL. Although most patients achieve complete response following front-line therapy, key unmet clinical needs include reducing the relapse rate, decreasing acute and...

Apr

Today In Oncology

Search Results

Your search for Syed A. Abutalib, MD and Alex Francisco Herrera, MD,Syed A. Abutalib, MD and Alex Francisco Herrera, MD matches 2 pages

Early-Stage Classic Hodgkin Lymphoma

Advanced-Stage Classical Hodgkin Lymphoma

TB Vaccination Could Enhance BCG Response in Patients With Non-Muscle-Invasive Bladder Cancer, Study Finds

Study Finds Standard Chemoradiation Therapy Superior to Deintensification Approaches for HPV-Related Oropharyngeal Cancer

Daily Physical Activity Even at Light Intensities May Reduce Cancer Risk

Could Brain Imaging Plus VR Minimize Cancer-Related Pain

Presymptomatic Awareness of BRCA1/BRCA2 Status and Outcomes in Ovarian Cancer